Management of hypertension and renin-angiotensin-aldosterone system blockade in adults with diabetic kidney disease: Association of British Clinical Diabetologists and the Renal Association UK guideline update 2021
Debasish Banerjee(Toyota Motor Corporation (Switzerland)), Indranil Dasgupta(University Hospitals Birmingham NHS Foundation Trust), Adnan Sharif(Queen Elizabeth Hospital Birmingham), Dipesh Patel(Royal Free London NHS Foundation Trust), Patrick B. Mark(Queen Elizabeth University Hospital), Mona Wahba(St Helier Hospital), Rosa Montero(King's College London), Janaka Karalliedde(St Thomas' Hospital), Peter Winocour(East and North Hertfordshire NHS Trust), Ana Pokrajac(West Hertfordshire Hospitals NHS Trust), P. De(Birmingham City Hospital), Steve Baín(Swansea University), Andrew Frankel(Imperial College Healthcare NHS Trust), Tahseen A Chowdhury(Royal London Hospital), Sagen Zac‐Varghese(East and North Hertfordshire NHS Trust), Damian Fogarty(Belfast Health and Social Care Trust)
Cited by 81
Related Papers
Chronic Kidney Disease and Coronary Artery Disease
|Journal of the American College of Cardiology|2019|716
Proceedings From an International Consensus Meeting on Posttransplantation Diabetes Mellitus: Recommendations and Future Directions
|American Journal of Transplantation|2014|522
Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans
|Journal of Clinical Investigation|2010|516